GO:0071321 cellular response to cGMP: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071321 (cellular response to cGMP) describes how a single cell changes its state or activity in response to cyclic GMP (cGMP).
• cGMP is generated by soluble and particulate guanylate cyclases and is degraded by phosphodiesterases, most notably PDE5 and PDE3.
• The canonical downstream effectors are cGMP-dependent protein kinase (cGKI/PKG), cyclic nucleotide-gated channels, and cGMP-regulated phosphodiesterases.
• In cardiac myocytes, cGMP/cGKI signaling modulates contractility, hypertrophy, and fibroblast-myocyte crosstalk.
• In neurons and sensory cells, cGMP signaling controls axon guidance, osmotic avoidance, and shear-stress sensing.
• Dysregulated cGMP signaling is implicated in retinal degeneration, cardiovascular disease, and oocyte meiotic arrest.
Description
Cyclic guanosine 3',5'-monophosphate (cGMP) is a second messenger that transduces extracellular and intracellular signals into rapid cellular responses. GO:0071321, cellular response to cGMP, captures the set of processes by which a cell changes its state or activity following a cGMP stimulus, including changes in movement, secretion, enzyme activity, and gene expression. This term is distinct from cGMP metabolism itself; it specifically describes the downstream cellular response to the cyclic nucleotide. Because cGMP is short-lived and acts through a limited set of effectors, the response is tightly controlled in space and time. Researchers study GO:0071321 to understand how nitric oxide (NO), natriuretic peptides, and other cGMP-elevating signals are translated into physiological outputs in the heart, vasculature, nervous system, and reproductive tissues. The pathway is also a major pharmacological target: PDE5 inhibitors, soluble guanylate cyclase stimulators, and PKG modulators all act by altering cellular cGMP responses. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of the genes, mechanisms, disease links, and experimental methods associated with GO:0071321.
cellular response to cGMP At A Glance
| GO ID | GO:0071321 |
|---|---|
| GO term | cellular response to cGMP |
| Ontology | biological_process |
| Synonym | cellular response to 3',5' cGMP; cellular response to 3',5'-cGMP; cellular response to cyclic GMP; cellular response to guanosine 3',5'-cyclophosphate |
| Major function | Transduces cGMP signals into changes in cell movement, secretion, enzyme activity, and gene expression |
| Key effectors | cGMP-dependent protein kinase (PKG/cGKI), cyclic nucleotide-gated channels, cGMP-regulated phosphodiesterases |
| Upstream signals | Nitric oxide (NO), natriuretic peptides, and other guanylate cyclase activators |
| Termination | Phosphodiesterases (e.g., PDE5, PDE3) hydrolyze cGMP to limit the response |
What Is GO:0071321?
According to QuickGO, GO:0071321 (cellular response to cGMP) is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cGMP (cyclic GMP, guanosine 3',5'-cyclophosphate) stimulus. In other words, it is the cell-level response to cGMP, not the synthesis or degradation of cGMP itself. The term is a biological process and includes synonyms such as cellular response to 3',5' cGMP, cellular response to 3',5'-cGMP, cellular response to cyclic GMP, and cellular response to guanosine 3',5'-cyclophosphate.
Why Is cellular response to cGMP Important in Cell Biology?
GO:0071321 is important because cGMP is a central second messenger in cardiovascular, neuronal, and reproductive physiology, and its dysregulation contributes to human disease. In the heart, cGMP/cGKI signaling modulates contractility, hypertrophy, and fibroblast-myocyte communication, making it a key node in heart failure and arrhythmia research. In the retina, excessive or mislocalized cGMP signaling drives photoreceptor degeneration, and PKG inhibition preserves photoreceptor viability in a mouse model of autosomal dominant retinitis pigmentosa. In the nervous system, cGMP responses control axon guidance and sensory behaviors such as osmotic avoidance and shear-stress sensing. In reproduction, cGMP maintains oocyte meiotic arrest, a process essential for normal egg maturation. Because cGMP levels are controlled by phosphodiesterases and guanylate cyclases, the pathway is highly druggable, and understanding GO:0071321 is essential for developing targeted therapies.
• Cardiovascular disease: cGMP/cGKI signaling regulates cardiac contractility, hypertrophy, and fibroblast-myocyte crosstalk.
• Retinal degeneration: PKG inhibition preserves photoreceptor viability and function in a mouse model of autosomal dominant retinitis pigmentosa.
• Neuronal development: Rac-cGMP signaling controls axon guidance and growth cone collapse.
• Sensory behavior: cGMP responses mediate osmotic avoidance and shear-stress sensing in C. elegans.
• Reproductive biology: cGMP maintains oocyte meiotic arrest and regulates egg maturation.
• Pharmacology: PDE5 inhibitors and guanylate cyclase modulators act by altering cellular cGMP responses.
• Signal termination: phosphodiesterases such as PDE5 and PDE3 shape the amplitude and duration of cGMP responses.
• Cell-type specificity: cGMP responses differ between cardiac myocytes, neurons, and oocytes, requiring context-specific models.
What Happens During cellular response to cGMP?
cGMP generation and reception
In simple terms: A cell first receives a cGMP signal, usually made by guanylate cyclases in response to nitric oxide or natriuretic peptides.
The cellular response to cGMP begins when guanylate cyclases produce cGMP from GTP. Soluble guanylate cyclase is activated by nitric oxide (NO), while particulate guanylate cyclases are activated by natriuretic peptides. In cardiac myocytes, fibroblast-derived NO can increase cGMP in neighboring myocytes, demonstrating paracrine cGMP signaling. The newly synthesized cGMP then binds to effector proteins, initiating the cellular response.
Activation of cGMP-dependent protein kinase (PKG/cGKI)
In simple terms: The main way cells respond to cGMP is by turning on PKG, an enzyme that adds phosphate groups to target proteins.
cGMP binds to the regulatory domain of cGMP-dependent protein kinase (cGKI/PKG), relieving autoinhibition and activating its kinase activity. Activated PKG phosphorylates diverse substrates, including ion channels, contractile proteins, and transcription factors, thereby changing cell movement, secretion, and gene expression. In cardiac myocytes, cGMP/cGKI signaling modulates contractility and hypertrophy. In photoreceptors, PKG activity contributes to degeneration, and its inhibition is protective.
Cyclic nucleotide-gated channels and other effectors
In simple terms: cGMP can also directly open certain ion channels, changing the electrical state of the cell.
Beyond PKG, cGMP directly gates cyclic nucleotide-gated (CNG) channels, which are especially important in sensory neurons and photoreceptors. In C. elegans, cGMP signaling through CNG channels mediates osmotic avoidance and shear-stress sensing. cGMP also regulates phosphodiesterases, creating feedback loops that shape the response.
Signal termination by phosphodiesterases
In simple terms: To stop the response, enzymes called phosphodiesterases break down cGMP.
Phosphodiesterases (PDEs) hydrolyze cGMP to 5'-GMP, terminating the signal. PDE5 is a cGMP-specific PDE, and its kinetics have been characterized in cellular NO/cGMP/PDE5 pathways. In cardiac fibroblasts and myocytes, cGMP can inhibit PDE3, increasing cAMP and illustrating crosstalk between cyclic nucleotide pathways. This termination step is critical for maintaining the specificity and duration of the cellular response to cGMP.
Downstream physiological outputs
In simple terms: The final result is a change in how the cell behaves, such as contracting, moving, or maturing.
The integrated cellular response to cGMP produces diverse physiological outputs. In the heart, it modulates contractility and hypertrophy. In neurons, it controls axon guidance and sensory behaviors. In oocytes, cGMP maintains meiotic arrest, and its regulation is essential for normal egg maturation. These outputs depend on the specific effectors expressed in each cell type.
Key Genes Involved in GO:0071321 cellular response to cGMP
The following genes and proteins are central to the cellular response to cGMP (GO:0071321), based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKG1 | cGMP-dependent protein kinase I (cGKI/PKG); phosphorylates downstream targets | Cardiac contractility, hypertrophy, and photoreceptor degeneration |
| PRKG2 | cGMP-dependent protein kinase II; intestinal and skeletal functions | cGMP signaling in non-cardiac tissues |
| GUCY1A1 | Soluble guanylate cyclase subunit alpha-1; synthesizes cGMP in response to NO | NO-cGMP signaling in cardiovascular and neuronal cells |
| GUCY1B1 | Soluble guanylate cyclase subunit beta-1; heme-binding subunit | NO sensing and cGMP generation |
| NPR1 | Natriuretic peptide receptor A; particulate guanylate cyclase | cGMP generation in response to natriuretic peptides |
| NPR2 | Natriuretic peptide receptor B; particulate guanylate cyclase | Oocyte meiotic arrest and cGMP signaling |
| PDE5A | cGMP-specific phosphodiesterase; degrades cGMP | Termination of cGMP response; PDE5 inhibitor target |
| PDE3A | cAMP/cGMP-inhibited phosphodiesterase; crosstalk with cAMP | Cardiac fibroblast-myocyte cGMP/cAMP crosstalk |
| CNGA1 | Cyclic nucleotide-gated channel subunit; directly gated by cGMP | Photoreceptor and sensory neuron responses |
| CNGB1 | Cyclic nucleotide-gated channel subunit | Retinal cGMP signaling |
| RAC1 | Rho-family GTPase; mediates Rac-cGMP signaling | Axon guidance and growth cone collapse |
| NOS1 | Neuronal nitric oxide synthase; produces NO to activate soluble guanylate cyclase | Neuronal and cardiac cGMP signaling |
| NOS3 | Endothelial nitric oxide synthase; produces NO in endothelium | Vascular cGMP signaling |
| TAX-2 | C. elegans guanylate cyclase; involved in sensory signaling | Osmotic avoidance and shear-stress sensing |
| TAX-4 | C. elegans cyclic nucleotide-gated channel subunit | Sensory cGMP responses |
| GCY-35 | C. elegans guanylate cyclase; oxygen sensing | cGMP-dependent sensory behavior |
| PKG-1 | C. elegans cGMP-dependent protein kinase | Osmotic avoidance and sensory signaling |
| CNGC | Cyclic nucleotide-gated channel family | cGMP-gated ion flux in sensory cells |
How Is cellular response to cGMP Regulated?
The cellular response to cGMP is regulated at multiple levels. Synthesis is controlled by soluble guanylate cyclases (activated by NO) and particulate guanylate cyclases (activated by natriuretic peptides). Degradation is controlled by phosphodiesterases, especially PDE5 and PDE3, which set the amplitude and duration of the cGMP signal. Compartmentalization of these enzymes ensures that cGMP responses are localized to specific subcellular domains. Crosstalk with cAMP signaling occurs through cGMP-inhibited PDE3, which can increase cAMP when cGMP is elevated. In addition, PKG activity is modulated by phosphorylation, subcellular localization, and interacting proteins. In photoreceptors, excessive PKG activity contributes to degeneration, and its inhibition is protective, indicating that negative regulation of cGMP/PKG signaling is critical for cell survival.
cellular response to cGMP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKG1 | Retinitis pigmentosa; cardiac hypertrophy | Prkg1 knockout or point-mutation mouse; PKG inhibitor treatment |
| PDE5A | Cardiovascular disease; erectile dysfunction | Pde5a knockout mouse; PDE5 inhibitor treatment |
| NPR2 | Oocyte meiotic arrest; reproductive disorders | Npr2 knockout or knock-in mouse oocyte model |
| GUCY1A1 | Hypertension; cardiovascular disease | Gucy1a1 knockout mouse; NO-cGMP signaling assays |
| RAC1 | Axon guidance defects; neurodevelopmental disorders | Rac1 conditional knockout or point-mutation neurons |
Cardiovascular disease
cGMP/cGKI signaling in cardiac myocytes regulates contractility, hypertrophy, and fibroblast-myocyte communication. Dysregulation of this pathway contributes to heart failure and arrhythmias, making it a major therapeutic target. PDE5 inhibitors and guanylate cyclase stimulators are used to modulate cGMP responses in cardiovascular disease.
Retinal degeneration
In autosomal dominant retinitis pigmentosa, excessive cGMP/PKG signaling drives photoreceptor death. Pharmacological inhibition of PKG preserves photoreceptor viability and function in a mouse model, highlighting the disease relevance of GO:0071321.
Reproductive disorders
cGMP signaling maintains oocyte meiotic arrest, and disruption of this pathway can lead to premature oocyte maturation and infertility. Understanding the cellular response to cGMP in oocytes is therefore important for reproductive medicine.
Neurological and sensory disorders
cGMP responses control axon guidance and sensory behaviors such as osmotic avoidance and shear-stress sensing. Defects in these processes may contribute to neurodevelopmental and sensory disorders, although specific human disease links require further study.
From cellular response to cGMP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PRKG1 mediate cGMP-induced cardiac hypertrophy? | Prkg1 knockout or point-mutation (kinase-dead) mouse |
| Does PDE5A regulate cGMP amplitude in cardiac myocytes? | Pde5a knockout or overexpression in cardiomyocytes |
| Does NPR2 maintain oocyte meiotic arrest? | Npr2 knockout or knock-in mouse oocytes |
| Does cGMP-gated channel activity mediate shear-stress sensing? | C. elegans tax-4 or tax-2 mutants |
| Does Rac-cGMP signaling control axon guidance? | Rac1 conditional knockout or tagged knock-in in neurons |
| Does PKG inhibition protect photoreceptors? | Prkg1 knockout or point-mutation in retinitis pigmentosa mouse model |
How to Study the cellular response to cGMP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell cGMP imaging | Real-time cGMP concentration and dynamics | NO/cGMP/PDE5 kinetics; compartmentalization |
| Phosphoproteomics | PKG-dependent phosphorylation events | Mapping cGMP/cGKI substrates in cardiac myocytes |
| Patch-clamp electrophysiology | cGMP-gated ion channel currents | Photoreceptor and sensory neuron responses |
| Behavioral assays | Osmotic avoidance, shear-stress sensing | C. elegans cGMP signaling genetics |
| Western blot | Protein expression and phosphorylation | PKG activation and downstream targets |
| cGMP ELISA | Total cellular cGMP levels | Guanylate cyclase and PDE activity |
| FRET biosensors | cGMP and PKG activity in live cells | Spatiotemporal signaling studies |
| CRISPR knockout | Loss-of-function phenotypes | Causal gene validation in cGMP pathway |
Live-cell cGMP imaging
Genetically encoded cGMP sensors (e.g., cGES-DE5) allow real-time visualization of cGMP dynamics in living cells. These sensors have been used to study NO/cGMP/PDE5 kinetics and compartmentalization. Imaging can reveal how cGMP responses differ between cell types and subcellular domains.
Phosphoproteomics for PKG substrates
Because PKG phosphorylates many downstream targets, phosphoproteomics can identify substrates and quantify changes in phosphorylation upon cGMP stimulation. This approach has been used to map cGMP/cGKI targets in cardiac myocytes. Combining phosphoproteomics with PKG inhibition or knockout helps distinguish direct from indirect effects.
Electrophysiology for CNG channels
Patch-clamp electrophysiology measures cGMP-gated currents through cyclic nucleotide-gated channels. This method is essential for studying sensory responses in photoreceptors and C. elegans neurons. It can be combined with cGMP perfusion or photolysis to control ligand delivery.
Behavioral assays in model organisms
In C. elegans, osmotic avoidance and shear-stress sensing assays link cGMP signaling to behavior. These assays have been used to identify genes such as tax-2, tax-4, and gcy-35. Behavioral genetics complements biochemical and imaging approaches.
How CRISPR Can Be Used to Study GO:0071321 cellular response to cGMP
Knockout
CRISPR knockout of cGMP pathway genes (e.g., PRKG1, PDE5A, NPR2) enables loss-of-function studies to determine whether a gene is required for the cellular response to cGMP. For example, Prkg1 knockout mice have been used to study cardiac hypertrophy and photoreceptor degeneration. Knockout of Npr2 in oocytes disrupts meiotic arrest.
Point Mutation
Point mutations can be introduced to dissect specific domains or catalytic residues. For example, kinase-dead PRKG1 point mutants can separate cGMP binding from kinase activity. Disease-associated mutations in PDE5A or NPR2 can be modeled to understand altered cGMP responses.
Knock-in
Knock-in of tagged or reporter alleles allows visualization and purification of cGMP pathway components. Tagged PRKG1 or PDE5A knock-in cells can be used for imaging and proteomics. Knock-in of disease mutations (e.g., in NPR2) creates isogenic models for mechanistic studies.
Overexpression
Overexpression of cGMP pathway genes (e.g., PDE5A, PKG) can amplify or suppress the cellular response to cGMP. Overexpression of PDE5A reduces cGMP levels and blunts the response. Overexpression of PKG can enhance downstream phosphorylation and phenotypic outputs.
How EDITGENE Supports cellular response to cGMP Research
Researchers studying cellular response to cGMP-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with it. CRISPR-based models provide the gold-standard approach for establishing causality, from complete knockout to precise point mutations and tagged knock-ins. EDITGENE offers a comprehensive suite of CRISPR services tailored to cGMP signaling research, enabling reproducible, publication-ready experiments.
Contact EDITGENE today to design your custom CRISPR model for cellular response to cGMP research.
Frequently Asked Questions About cellular response to cGMP
What is cellular response to cGMP (GO:0071321)?
It is the biological process by which a cell changes its state or activity in response to a cGMP stimulus, including changes in movement, secretion, enzyme activity, and gene expression.
What genes are involved in cellular response to cGMP?
Key genes include PRKG1 (PKG), GUCY1A1, GUCY1B1, NPR1, NPR2, PDE5A, PDE3A, CNGA1, CNGB1, and RAC1.
How does cGMP activate PKG?
cGMP binds to the regulatory domain of PKG (cGKI), relieving autoinhibition and activating its kinase activity to phosphorylate downstream targets.
What diseases are linked to cGMP signaling?
Cardiovascular disease, retinitis pigmentosa, reproductive disorders, and neurological/sensory disorders have been linked to cGMP signaling.
How is cGMP degraded?
Phosphodiesterases, especially PDE5 and PDE3, hydrolyze cGMP to 5'-GMP, terminating the signal.
What is the role of cGMP in the heart?
cGMP/cGKI signaling modulates cardiac contractility, hypertrophy, and fibroblast-myocyte communication.
Can CRISPR be used to study cGMP signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study cGMP pathway genes.
What methods are used to measure cGMP responses?
Live-cell cGMP imaging, phosphoproteomics, patch-clamp electrophysiology, and behavioral assays are commonly used.
What is the role of cGMP in oocyte maturation?
cGMP maintains oocyte meiotic arrest, and its regulation is essential for normal egg maturation.
How does cGMP signaling affect photoreceptors?
Excessive cGMP/PKG signaling drives photoreceptor degeneration, and PKG inhibition is protective in retinitis pigmentosa models.
Conclusion
GO:0071321 (cellular response to cGMP) is a fundamental biological process that translates the second messenger cGMP into diverse cellular outputs, from cardiac contractility to neuronal guidance and oocyte maturation. Its dysregulation is implicated in cardiovascular disease, retinal degeneration, and reproductive disorders, making it a high-value target for both basic and translational research. CRISPR-based models, combined with imaging, proteomics, and electrophysiology, provide powerful tools to dissect the pathway and identify new therapeutic opportunities.
References
- 1. Adler J et al.. 2020. Targets of cGMP/cGKI in Cardiac Myocytes.. J Cardiovasc Pharmacol 75(6):494-507 PMID: 32168155
- 2. Yu J et al.. 2017. An Aversive Response to Osmotic Upshift in Caenorhabditis elegans.. eNeuro 4(2) PMID: 28451641
- 3. Zhang Z et al.. 2024. Shear stress sensing in C. elegans.. Curr Biol 34(22):5382-5391.e3 PMID: 39471806
- 4. Menges L et al.. 2023. It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3.. Commun Biol 6(1):504 PMID: 37165086
- 5. Zhu Y et al.. 2025. Protein kinase G inhibition preserves photoreceptor viability and function in a new mouse model for autosomal dominant retinitis pigmentosa.. Cell Death Dis 16(1):575 PMID: 40738887
- 6. Guo D et al.. 2007. A Rac-cGMP signaling pathway.. Cell 128(2):341-55 PMID: 17254971
- 7. Mo E et al.. 2004. Kinetics of a cellular nitric oxide/cGMP/phosphodiesterase-5 pathway.. J Biol Chem 279(25):26149-58 PMID: 15075333
- 8. Pan B et al.. 2019. The art of oocyte meiotic arrest regulation.. Reprod Biol Endocrinol 17(1):8 PMID: 30611263
